| ²é¿´: 507 | »Ø¸´: 2 | ||
caisanrenjuľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
¹ØÓÚÈ«»ùÒò×éѧµÄÎÊÌ⣬¿Î³Ì×÷Òµ²»»á°¡
|
|
¼ÙÉèÄãÊÇÒ»¸öÄêÇáµÄÑо¿ÈËÔ±£¬Ñо¿ÓйظßѪѹµÄÒÅ´«Ò׸ÐÐÔ¡£ Äã×öÁËÒ»Ì×GWAS£¨È«»ùÒò×é·ÖÎö£©ÔÚÒ»¸öÐÂÎïÖÖÉÏ£¬²¢·¢ÏÖÒ»¸ö¶à̬ÐÔλµãºÍÕâ¸ö¼²²¡Óкܴó¹ØÏµ£¬Õâ¸öλµãÊÇ·Ö²¼ÔÚ»ùÒò¼äµÄµØÇø£¬´ÓGEOÊý¾Ý¿â£¬Äã¿ÉÒÔÕÒµ½Ò»¸öÕâ¸öÎïÖÖµÄRNA-seqÊý¾Ý¡£ Çë×¼±¸Ò»¸öʵÑ鼯»®ÓÃÓÚ²ûÃ÷Õâ¸ö»ùÒò±äÒìÊÇÔõô¶Ô¸ßѪѹÓÐ×÷Óõġ£ ±¾ÈË·Ç»ùÒòÏà¹ØµÄרҵ£¬ËùÒÔ·ÒëµÄÊ®·Ö´Ö²Ú¡£ÒÔÏÂÊÇÓ¢ÎÄÔÌ⣺ Suppose you are a young investigator working on the genetic susceptibility factors underpinning hypertension. Yor performed GWAS in a new species X and identified one polymorphism site significantly associated with the disease. On the basis of the genome annotation (not well-annotated as it was newly-sequenced), the site is located in an intergenic region. From GEO database, you could find on RNA-Seq dataset performed in this species(densities of expression tags were shown in the figure). Please prepare a research plan to clarify how this genetic variation contribute to hypertension susceptibility. Óиöͼ¾Í²»Ìù³öÀ´ÁË£¬´óÒâÊÇÁ¬¸ö»ùÒòÖØµãÓиöλµãÒ²Óбí´ï¡£Çë¸÷·´óÉñ°ï°ï棬¸Ð¼¤ÌéÁã |
» ²ÂÄãϲ»¶
º¬·úÌÇÆ¤Öʼ¤ËصÄÍâÓÿ¹Ñ×ÀûÆ÷´×Ëá·úÇáËÉ
ÒѾÓÐ0È˻ظ´
°¢ÄªÄÎΤ£¨Amenamevir£©£º½âÐýø-ÒýÎïø°ÐÏò·Ö×ÓµÄ½á¹¹ÌØÕ÷ÓëºÏ³É·¾¶È«½âÎö
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ164È˻ظ´
ÀûÈð³µ¥¿¹£º°ÐÏòKIRµÄNKϸ°û¼ì²éµã¹¤¾ß¿¹Ì壬½á¹¹»ù´¡Óë¿ÆÑÐÓ¦ÓÃÈ«½âÎö
ÒѾÓÐ0È˻ظ´
Wnt-C59£ºPORCN°ÐÏò»¯Ñ§Ì½Õ룬WntÐźÅͨ·×è¶Ï»úÖÆÓë¿ÆÑÐÓ¦ÓÃÈ«½âÎö
ÒѾÓÐ0È˻ظ´
Fexaramine£º³¦µÀÏÞÖÆÐÔFXR»¯Ñ§Ì½Õ룬½á¹¹ÌØÕ÷ÓëÐźÅͨ·Ñо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
NVS-STG2£º°ÐÏòSTING¿çĤÓòµÄ·Ö×Ó½ºÀ༤¶¯¼Á£¬½á¹¹ÌØÕ÷Óë¹Ñ¾Û»¯»úÖÆÑо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
DOTA-GPC3ëÄ£¨CAS 3066439-94-6£©£ºË«¹¦ÄÜ·Ö×Ó̽ÕëǰÌåµÄ½á¹¹ÌØÕ÷Óë±ê¼ÇÓ¦ÓýâÎö
ÒѾÓÐ0È˻ظ´
¿ÆÑÐÓà TLR7/8 Ë«¼¤¶¯¼ÁÔõôѡ£¿ÏÖ»õÓëÖÊ¿ØÒªµã
ÒѾÓÐ0È˻ظ´
SEL120-34A HCl£ºCDK8/CDK19¸ßÑ¡ÔñÐÔ¼¤Ã¸ÒÖÖÆ¼Á
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ϸ¾úÈ«»ùÒò×é²âÐò
ÒѾÓÐ5È˻ظ´
2014Äê¹ú¼Ò863¼Æ»®»ò¿Æ¼¼Ö§³Å¼Æ»®É걨ÒÉÎÊ£¿
ÒѾÓÐ5È˻ظ´
ÇóÖúÈ«»ùÒò×鹨Áª·ÖÎöµÄÓÅÊÆ
ÒѾÓÐ6È˻ظ´
¹ØÓÚִҵҩʦ¿¼ÊÔ£¨ÖÐҩѧ£©µÄ¼¸¸öÒÉÎÊ£¬·³Çë¸÷λ´óϺ½â´ð
ÒѾÓÐ14È˻ظ´
¡¾×ÊÁÏ¡¿·¬ÇÑ»ùÒò×éÍê³É²âÐò£¨¸½NatureÈ«ÎÄ£©
ÒѾÓÐ73È˻ظ´
ÔõÑùÔÚNCBIÖвéÕÒÒ»ÎïÖÖµÄÈ«»ùÒò×飿
ÒѾÓÐ12È˻ظ´
ÖйúË®²ú¿ÆÑ§Ñо¿Ôº Ë®²úÉúÎïÓ¦ÓûùÒò×éÑо¿ÖÐÐÄ ÕÐÆ¸¹«¸æ
ÒѾÓÐ47È˻ظ´
Ò»¸ö¹ØÓÚÈ«»ùÒò×é²âÐòµÄÎÊÌâ
ÒѾÓÐ6È˻ظ´
¡¾Journal Club¡¿µÚ3½² Ë®µ¾È«»ùÒò×é»ùÒòÍøÂçÉúÎïÐÅϢѧƽ̨µÄ½¨Á¢
ÒѾÓÐ33È˻ظ´
¡¾¿Î¼þ¡¿»ùÒò×éѧÓëҽѧ£¨±±¾©´óѧҽѧ²¿£©
ÒѾÓÐ174È˻ظ´
ºê»ùÒò×éѧ¼¼ÊõÔÚʶ±ð¸´ÔÓ»·¾³ÑùÆ·ÖÐ΢ÉúÎïµÄ½á¹¹×é³É¼°¹¦ÄÜÖеÄÓ¦ÓÃ
ÒѾÓÐ5È˻ظ´
°×²ËÈ«»ùÒò×éͼÆ×¡°Ãյס±½ÒÏþ
ÒѾÓÐ10È˻ظ´
¡¾¿Î¼þ¡¿Ò©Îï»ùÒò×éѧÓë¸öÌ廯¸øÒ©£¨ÖØÇìÒ½¿Æ´óѧ£©
ÒѾÓÐ104È˻ظ´
»ª´ó»ùÒòÉúÎïÐÅϢѧ--ÊîÆÚÅàѵ°à
ÒѾÓÐ4È˻ظ´
À¶°×°ßɸѡ³öÏÖµÄÎÊÌâ
ÒѾÓÐ11È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿Ñ°ÕÒ»ùÒò×éÐòÁÐÖеĵ¥¿½±´»ùÒò
ÒѾÓÐ8È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿Çë½ÌÖ²ÎïRNAÌáÈ¡ºÍת¼×éѧ
ÒѾÓÐ16È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿Ï¸¾ú»ùÒò×éDNAµÄÌáÈ¡·¨£¨CTAB/NaCl ·¨£©,ÌáÈ¡µÄDNAÊÇ·ñΪϸ¾ú×ÜDNA? ·Ç³
ÒѾÓÐ11È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿»ùÒò¿½±´ÊýµÄ¸ÅÄî
ÒѾÓÐ8È˻ظ´
gaoyang636
ľ³æ (ÖøÃûдÊÖ)
- MolEPI: 5
- Ó¦Öú: 202 (´óѧÉú)
- ½ð±Ò: 4111.4
- É¢½ð: 7
- ºì»¨: 14
- Ìû×Ó: 1108
- ÔÚÏß: 159.8Сʱ
- ³æºÅ: 384065
- ×¢²á: 2007-05-27
- רҵ: »ùÒò×éѧ
2Â¥2013-10-13 16:13:01
caisanrenju
ľ³æ (ÕýʽдÊÖ)
- MolEPI: 3
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 2054.5
- É¢½ð: 239
- ºì»¨: 2
- Ìû×Ó: 411
- ÔÚÏß: 129.1Сʱ
- ³æºÅ: 1263848
- ×¢²á: 2011-04-13
- רҵ: ʳƷ¿ÆÑ§»ù´¡
3Â¥2013-10-13 16:47:22










»Ø¸´´ËÂ¥
50